Cumberland Pharmaceuticals (CPIX) Other Operating Expenses (2010 - 2026)

Cumberland Pharmaceuticals has reported Other Operating Expenses for 17 years, with the latest figure at $4.6 million in Q1 2026.

• Quarterly Other Operating Expenses rose 24.56% year-over-year to $4.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.2 million (up 74.51% YoY) and the FY2025 annual result came in at $16.3 million, changed N/A from the prior year.
• Other Operating Expenses slipped to $4.6 million in Q1 2026 per CPIX's latest filing, from $4.8 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $8.4 million in Q1 2022 and troughed at -$4.5 million in Q4 2024.
• A 5-year average of $4.8 million and a median of $4.9 million in 2023 frame the typical range for Other Operating Expenses.
• The sharpest annual moves came in 2023 and 2024: Other Operating Expenses surged 310.5% in 2023, then sank 162.02% in 2024.
• Over 5 years, Other Operating Expenses stood at -$3.5 million in 2022, then soared by 310.5% to $7.3 million in 2023, then tumbled by 162.02% to -$4.5 million in 2024, then soared by 205.63% to $4.8 million in 2025, then retreated by 3.39% to $4.6 million in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $4.6 million, $4.8 million, and $3.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.